MEDIA AREA

PRESS RELEASES

View and download our latest press releases, sorted by date. For any information request, please send it directly to us via the contact form.

Cardiawave confirms the safety of Valvosoft®, its non-invasive ultrasound treatment for aortic stenosis.

June 14, 2022

14/06/2022 Cardiawave confirms the safety of Valvosoft®, its non-invasive ultrasound treatment for aortic stenosis. DOWNLOAD THE PRESS RELEASE > DOWNLOAD THE PRESS RELEASE (FR) > …

Cardiawave announces the authorization by the French National Agency for the Safety of Medicines and Health Products (ANSM) to proceed with a new clinical study in France.

May 2, 2022

02/05/2022 Cardiawave announces the authorization by the French National Agency for the Safety of Medicines and Health Products (ANSM) to proceed with a new clinical study in France. DOWNLOAD …

Cardiawave announces the success of its clinical trial to treat aortic stenosis.

March 22, 2022

22/03/2022 Cardiawave announces the success of its clinical trial to treat aortic stenosis. DOWNLOAD THE PRESS RELEASE > DOWNLOAD THE PRESS RELEASE (FR) > << Press Releas…

Search

MEDIA AREA

PRESS RELEASES

Cardiawave confirms the safety of Valvosoft®, its non-invasive ultrasound treatment for aortic stenosis.

Cardiawave announces the authorization by the French National Agency for the Safety of Medicines and Health Products (ANSM) to proceed with a new clinical study in France.

Cardiawave announces the success of its clinical trial to treat aortic stenosis.

l Latest news

l Our social networks

l Contact Us